Rita Khoury1, Henry A Nasrallah2. 1. Department of Psychiatry and Behavioral Neuroscience, Saint Louis University School of Medicine, United States. Electronic address: rita.khoury@health.slu.edu. 2. Department of Psychiatry and Behavioral Neuroscience, Saint Louis University School of Medicine, United States.
Abstract
BACKGROUND: Studies linking neuro-inflammation to psychotic episodes has been rapidly expanding. Assessments of changes in inflammatory biomarkers in prodromal patients who subsequently convert to psychosis may help in predicting those likely to transition to psychosis. METHODS: We reviewed the literature for original studies that measured inflammatory biomarkers in individuals at clinical high risk for psychosis (CHR-P), and compared pro-inflammatory biomarker data between converters and non-converters to psychosis as well as in healthy controls. RESULTS: Our search yielded 15 studies. Our findings suggest a possible role of plasma levels of Interleukins-1β, 7, 8, matrix metalloproteinase (MMP)-8, cortisol, albumin and salivary cortisol, measured at baseline, as predictors of psychotic transition. Both baseline C-reactive protein (CRP) and Interleukin-6 levels were not shown to discriminate between converters and non-converters to psychosis. The dearth of longitudinal biomarker measures, before and after treating the psychotic episodes, was a limitation for assessing inflammatory biomarkers as trait vs state marker properties of biomarkers. DISCUSSION: Gaps of data in published studies prevent confirming whether inflammatory biomarkers are state or trait indicators of transition to psychosis in the CHR-P populations. Future investigations should be designed to longitudinally measure inflammatory biomarkers in order to navigate the extensive heterogeneity of the schizophrenia syndrome and its prodrome.
BACKGROUND: Studies linking neuro-inflammation to psychotic episodes has been rapidly expanding. Assessments of changes in inflammatory biomarkers in prodromal patients who subsequently convert to psychosis may help in predicting those likely to transition to psychosis. METHODS: We reviewed the literature for original studies that measured inflammatory biomarkers in individuals at clinical high risk for psychosis (CHR-P), and compared pro-inflammatory biomarker data between converters and non-converters to psychosis as well as in healthy controls. RESULTS: Our search yielded 15 studies. Our findings suggest a possible role of plasma levels of Interleukins-1β, 7, 8, matrix metalloproteinase (MMP)-8, cortisol, albumin and salivary cortisol, measured at baseline, as predictors of psychotic transition. Both baseline C-reactive protein (CRP) and Interleukin-6 levels were not shown to discriminate between converters and non-converters to psychosis. The dearth of longitudinal biomarker measures, before and after treating the psychotic episodes, was a limitation for assessing inflammatory biomarkers as trait vs state marker properties of biomarkers. DISCUSSION: Gaps of data in published studies prevent confirming whether inflammatory biomarkers are state or trait indicators of transition to psychosis in the CHR-P populations. Future investigations should be designed to longitudinally measure inflammatory biomarkers in order to navigate the extensive heterogeneity of the schizophrenia syndrome and its prodrome.
Authors: Thiago Duarte; Fernanda Barbisan; Beatriz Sadigurski Nunes da Cunha; Verônica Farina Azzolin; Bárbara Osmarin Turra; Marta Maria Medeiros Frescura Duarte; Ivo Emilio da Cruz Jung; Euler Esteves Ribeiro; Pedro Antônio do Prado-Lima; Ivana Beatrice Mânica da Cruz Journal: Inflammation Date: 2019-06 Impact factor: 4.092
Authors: Tyler R Prestwood; Roshanak Asgariroozbehani; Sally Wu; Sri Mahavir Agarwal; Ryan W Logan; Jacob S Ballon; Margaret K Hahn; Zachary Freyberg Journal: Behav Brain Res Date: 2021-01-14 Impact factor: 3.332
Authors: Felix L Nägele; Ofer Pasternak; Lisa V Bitzan; Marius Mußmann; Jonas Rauh; Marek Kubicki; Gregor Leicht; Martha E Shenton; Amanda E Lyall; Christoph Mulert Journal: World J Biol Psychiatry Date: 2020-07-09 Impact factor: 4.132
Authors: Martin Lennart Schulze Westhoff; Johannes Ladwig; Johannes Heck; Rasmus Schülke; Adrian Groh; Maximilian Deest; Stefan Bleich; Helge Frieling; Kirsten Jahn Journal: Brain Sci Date: 2021-12-23